標(biāo)題: Titlebook: Annual Update in Intensive Care and Emergency Medicine 2022; Jean-Louis Vincent Book 2022 The Editor(s) (if applicable) and The Author(s), [打印本頁(yè)] 作者: 多話 時(shí)間: 2025-3-21 19:42
書(shū)目名稱(chēng)Annual Update in Intensive Care and Emergency Medicine 2022影響因子(影響力)
書(shū)目名稱(chēng)Annual Update in Intensive Care and Emergency Medicine 2022影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Annual Update in Intensive Care and Emergency Medicine 2022網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Annual Update in Intensive Care and Emergency Medicine 2022網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Annual Update in Intensive Care and Emergency Medicine 2022被引頻次
書(shū)目名稱(chēng)Annual Update in Intensive Care and Emergency Medicine 2022被引頻次學(xué)科排名
書(shū)目名稱(chēng)Annual Update in Intensive Care and Emergency Medicine 2022年度引用
書(shū)目名稱(chēng)Annual Update in Intensive Care and Emergency Medicine 2022年度引用學(xué)科排名
書(shū)目名稱(chēng)Annual Update in Intensive Care and Emergency Medicine 2022讀者反饋
書(shū)目名稱(chēng)Annual Update in Intensive Care and Emergency Medicine 2022讀者反饋學(xué)科排名
作者: MILL 時(shí)間: 2025-3-21 22:40 作者: 駁船 時(shí)間: 2025-3-22 04:00
Annual Update in Intensive Care and Emergency Medicine 2022978-3-030-93433-0Series ISSN 2191-5709 Series E-ISSN 2191-5717 作者: 平靜生活 時(shí)間: 2025-3-22 06:05
Jean-Louis VincentComprehensively documents the most recent developments in experimental and clinical research in IC and EM.Written by acknowledged experts in the field.Broad appeal for all who work in internal medicin作者: GEST 時(shí)間: 2025-3-22 12:04 作者: 自愛(ài) 時(shí)間: 2025-3-22 14:40
Book 2022prehensive book. The chapters are written by well recognized experts in these fields. The book is addressed to everyone involved in intensive care and emergency medicine, anesthesia, surgery, internal medicine, and pediatrics..作者: 無(wú)目標(biāo) 時(shí)間: 2025-3-22 20:57 作者: brassy 時(shí)間: 2025-3-23 00:57
Boost Battery Charger Modeling,nd subsequent immunosuppression. Despite a better understanding of the immunopathogenesis of critical illness and advances in supportive care, no effective pharmacotherapy has been approved for ARDS or sepsis. Tetracyclines represent a class of bacteriostatic antibiotics with pleiotropic immunomodul作者: forestry 時(shí)間: 2025-3-23 02:20 作者: intricacy 時(shí)間: 2025-3-23 07:33
Efficiency Evaluation of Energy Systemsthese patients remains high. Adjunctive therapies have been used with the goal of improving outcomes. Extracorporeal hemoadsorption is an adjunctive therapy that can be easily combined with ECMO. Several devices are available; however, data supporting their use in this setting is limited. Case repor作者: 沐浴 時(shí)間: 2025-3-23 09:55 作者: 聯(lián)合 時(shí)間: 2025-3-23 15:46
Klaus Mathis MA in Economics,Deborah Shannonin healthy human beings to attain adequate oxygenation, but critically ill patients frequently need extra oxygen administration. The oxygenation status can continuously and non-invasively be monitored as oxygen saturation by pulse oximetry, while oxygen pressure is measured discontinuously and invas作者: SLING 時(shí)間: 2025-3-23 19:46
Klaus Mathis MA in Economics,Deborah Shannonpneumonia of varying severity resulting in respiratory failure. COVID-19 pneumonia patients require prolonged hospitalization and often critical care support including mechanical ventilation. Despite extensive research, current formulations and dose regimens of systemic therapeutics assessed for use作者: 悶熱 時(shí)間: 2025-3-24 02:03
Klaus Mathis MA in Economics,Deborah Shannontress syndrome (ARDS). In the case of ARDS arising due to coronavirus disease 2019 (COVID-19, CARDS), there is some debate as to whether the atypical pathophysiological characteristics of the disease, which lead to hypoxemia could warrant a modified approach to ventilator management, particularly wi作者: TATE 時(shí)間: 2025-3-24 03:18
Klaus Mathis MA in Economics,Deborah Shannonsitive end-expiratory pressure (PEEP)]) and dynamic (respiratory rate, inspiratory, and expiratory peak flow) variables may promote ventilator-induced lung injury (VILI), multiple organ dysfunction, and death. In clinical practice, any of these variables may be set abruptly, thus increasing the risk作者: justify 時(shí)間: 2025-3-24 08:04 作者: GAVEL 時(shí)間: 2025-3-24 12:12
Efficiency Assessment: Final Remarks phase. Laryngeal injury can contribute to failed extubation, aspiration pneumonia and prolonged duration of intensive care unit (ICU) stay. Injuries to the larynx may manifest as airway abnormalities, loss of voice or swallowing impairment and result in poorer patient outcomes. This chapter outline作者: flourish 時(shí)間: 2025-3-24 15:18
Introduction to Data Envelopment Analysis patients but also to de-resuscitate patients following hemodynamic stabilization. As fluid overload has also been implicated in weaning failure, the parameters of fluid responsiveness could thus also be used to optimize patient status before initiating weaning trails and extubation in order to prev作者: canonical 時(shí)間: 2025-3-24 19:33 作者: 有組織 時(shí)間: 2025-3-25 03:00 作者: Nucleate 時(shí)間: 2025-3-25 04:01 作者: Adrenal-Glands 時(shí)間: 2025-3-25 09:19 作者: 威脅你 時(shí)間: 2025-3-25 15:22
https://doi.org/10.1007/978-1-349-02071-3 host immune response at the cellular level, and the potential and challenges of mitochondria-targeted therapies in restoring immune homeostasis in critically ill patients. We also discuss the current available diagnostic tools or biomarkers for assessing the mitochondrial metabolism in patients, wh作者: CARK 時(shí)間: 2025-3-25 17:37 作者: 認(rèn)識(shí) 時(shí)間: 2025-3-25 23:50
Klaus Mathis MA in Economics,Deborah Shannonrobic glycolysis, causing energy depletion in the cells. Hyperoxia has direct toxic effects on the airways and lungs. Hyperoxemia in the cells and the mitochondria stimulates production of reactive oxygen species, which can cause cellular and organ injury. The results of studies on the effects of li作者: Headstrong 時(shí)間: 2025-3-26 00:50
Klaus Mathis MA in Economics,Deborah Shannong formulations could potentially achieve higher local drug concentrations and improve clinical outcomes with limited systemic adverse effects. Various nebulized therapeutic agents are currently undergoing clinical trials. Barriers affecting safe and effective nebulized therapies should be addressed 作者: nutrition 時(shí)間: 2025-3-26 08:12
Klaus Mathis MA in Economics,Deborah Shannonhan an abrupt increase in attenuating lung injury; nevertheless, an even more gradual increase did not prevent lung injury, suggesting the concept that VILI relates to repetitive cycling above a strain-injury level. In this chapter, we highlight pre-clinical and clinical evidence showing that slowin作者: Shuttle 時(shí)間: 2025-3-26 12:13
Magdalena Kapelko,Alfons Oude Lansinktective. Assessment of potential parenchymal injury must take into account stress and strain as the real physical quantities acting on the lung structures. Moreover, the lack of information regarding regional lung mechanics and deformation at the acinar level is likely the main determinant of these 作者: 偽書(shū) 時(shí)間: 2025-3-26 15:09 作者: 富饒 時(shí)間: 2025-3-26 17:26 作者: Evocative 時(shí)間: 2025-3-26 23:40 作者: animated 時(shí)間: 2025-3-27 05:01 作者: Scintigraphy 時(shí)間: 2025-3-27 06:44
Hit Early: Blocking Interleukin-1 in the Treatment of COVID-19 Pneumoniatratified randomization into treatment with standard-of-care and placebo or standard-of-care and anakinra. Treatment with anakinra showed 64% patient benefit toward less severe strata of the 11-point WHO Clinical Progression Scale by day 28. Progression into severe respiratory failure was prevented 作者: 詩(shī)集 時(shí)間: 2025-3-27 12:31 作者: incontinence 時(shí)間: 2025-3-27 16:43 作者: inflame 時(shí)間: 2025-3-27 21:39 作者: 蝕刻 時(shí)間: 2025-3-27 22:04 作者: 看法等 時(shí)間: 2025-3-28 04:29
Tidal Volume Challenge Test: Expanding Possibilitiesnous pressure and pulmonary artery occlusion pressure to predict fluid responsiveness. These dynamic tests, other than PLR, depend on heart-lung interactions that have some limitations for predicting fluid responsiveness, the most common being mechanical ventilation using low tidal volume. Among the作者: Heterodoxy 時(shí)間: 2025-3-28 06:35
Fluid Management in COVID-19 ICU Patientsnce of dynamic tests of fluid responsiveness and provides valuable measures of pulmonary edema and of lung capillary leakage. This allows the benefit/risk ratio of fluid infusion to be assessed in a personalized fashion.作者: Juvenile 時(shí)間: 2025-3-28 14:03
Electrolytes in the ICUrrow normal ranges and lead to new subsequent iatrogenic electrolyte abnormalities. The current chapter summarizes the (patho)physiology of electrolyte changes, with special attention to the interplay between different electrolytes. Additionally, we review the available evidence on the management of作者: 或者發(fā)神韻 時(shí)間: 2025-3-28 15:47 作者: 磨坊 時(shí)間: 2025-3-28 22:03 作者: 猛然一拉 時(shí)間: 2025-3-29 01:34 作者: 同謀 時(shí)間: 2025-3-29 05:40
Hemoadsorption Therapy During ECMO: Emerging Evidencethese patients remains high. Adjunctive therapies have been used with the goal of improving outcomes. Extracorporeal hemoadsorption is an adjunctive therapy that can be easily combined with ECMO. Several devices are available; however, data supporting their use in this setting is limited. Case repor作者: patriarch 時(shí)間: 2025-3-29 07:42
The Forgotten Circulation and Transpulmonary Pressure Gradientse gradient). This is the essential pressure that overcomes vascular resistance and is a cornerstone of hemodynamic resuscitation, enabling oxygenation and cardiac output. With advanced critical care echocardiography and possible resurgence in the use of contemporary pulmonary artery catheters, inten作者: cinder 時(shí)間: 2025-3-29 13:54 作者: 殘廢的火焰 時(shí)間: 2025-3-29 19:26
Nebulized Therapeutics for COVID-19 Pneumonia in Critical Carepneumonia of varying severity resulting in respiratory failure. COVID-19 pneumonia patients require prolonged hospitalization and often critical care support including mechanical ventilation. Despite extensive research, current formulations and dose regimens of systemic therapeutics assessed for use作者: 記成螞蟻 時(shí)間: 2025-3-29 19:50
Positive End-Expiratory Pressure in Invasive and Non-invasive Ventilation of COVID-19 Acute Respirattress syndrome (ARDS). In the case of ARDS arising due to coronavirus disease 2019 (COVID-19, CARDS), there is some debate as to whether the atypical pathophysiological characteristics of the disease, which lead to hypoxemia could warrant a modified approach to ventilator management, particularly wi作者: installment 時(shí)間: 2025-3-30 02:53
Personalized Mechanical Ventilation Settings: Slower Is Better!sitive end-expiratory pressure (PEEP)]) and dynamic (respiratory rate, inspiratory, and expiratory peak flow) variables may promote ventilator-induced lung injury (VILI), multiple organ dysfunction, and death. In clinical practice, any of these variables may be set abruptly, thus increasing the risk作者: 不近人情 時(shí)間: 2025-3-30 07:29 作者: 不適當(dāng) 時(shí)間: 2025-3-30 09:29 作者: 貪婪地吃 時(shí)間: 2025-3-30 13:57 作者: 蔑視 時(shí)間: 2025-3-30 20:27
Tidal Volume Challenge Test: Expanding Possibilitiesh increased complications, prolonged intensive care unit (ICU) stay and increased mortality, especially in patients with acute respiratory distress syndrome (ARDS). Therefore it is important to identify patients who will respond positively to fluid loading by increasing their cardiac output (fluid r作者: 鴿子 時(shí)間: 2025-3-30 23:37 作者: 不開(kāi)心 時(shí)間: 2025-3-31 02:40 作者: Incommensurate 時(shí)間: 2025-3-31 08:21
2191-5709 the field.Broad appeal for all who work in internal medicin.The Annual Update compiles reviews of the most recent developments in clinical intensive care and emergency medicine research and practice in one comprehensive book. The chapters are written by well recognized experts in these fields. The 作者: BIPED 時(shí)間: 2025-3-31 10:45
Introduction to Data Envelopment Analysisparameters of fluid responsiveness could thus also be used to optimize patient status before initiating weaning trails and extubation in order to prevent re-intubation due to fluid overload. In this chapter, we will discuss the physiologic considerations of the possible clinical use of fluid responsiveness in the context of weaning.作者: Ligament 時(shí)間: 2025-3-31 13:36 作者: Itinerant 時(shí)間: 2025-3-31 19:34
Book 2022prehensive book. The chapters are written by well recognized experts in these fields. The book is addressed to everyone involved in intensive care and emergency medicine, anesthesia, surgery, internal medicine, and pediatrics..
